Liao Jie, Hwang Sung Hee, Li Haonan, Liu Jun-Yan, Hammock Bruce D, Yang Guang-Yu
Department of Pathology, Northwestern University, Chicago, IL, U.S.A.
Department of Entomology and Cancer Center, University of California, One Shields Avenue, Davis, CA, U.S.A.
Anticancer Res. 2016 Jan;36(1):27-37.
Mutation of Kirsten rat sarcoma viral oncogene homolog (KRAS) and chronic pancreatitis are the most common pathogenic events involved in human pancreatic carcinogenesis. In the process of long-standing chronic inflammation, aberrant metabolites of arachidonic acid play a crucial role in promoting carcinogenesis, in which the soluble epoxide hydrolase (sEH), as a pro-inflammatory enzyme, generally inactivates anti-inflammatory epoxyeicosatrienoic acids (EETs). Herein, we determined the effect of our newly-synthesized novel compound trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide (t-CUPM), a dual inhibitor of sEH and RAF1 proto-oncogene serine/threonine kinase (c-RAF), on inhibiting the development of pancreatitis and pancreatic intraepithelial neoplasia (mPanIN) in LSL-Kras(G12D)/Pdx1-Cre mice. The results showed that t-CUPM significantly reduced the severity of chronic pancreatitis, as measured by the extent of acini loss, inflammatory cell infiltration and stromal fibrosis. The progression of low-grade mPanIN I to high-grade mPanIN II/III was significantly suppressed. Inhibition of mutant Kras-transmitted phosphorylation of mitogen-activated protein kinase's kinase/extracellular signal-regulated kinases was demonstrated in pancreatic tissues by western blots. Quantitative real-time polymerase chain reaction analysis revealed that t-CUPM treatment significantly reduced the levels of inflammatory cytokines including tumor necrosis facor-α, monocyte chemoattractant protein-1, as well as vascular adhesion molecule-1, and the levels of Sonic hedgehog and Gli transcription factor (Hedgehog pathway). Analysis of the eicosanoid profile revealed a significant increase of the EETs/dihydroxyeicosatrienoic acids ratio, which further confirmed sEH inhibition by t-CUPM. These results indicate that simultaneous inhibition of sEH and c-RAF by t-CUPM is important in preventing chronic pancreatitis and carcinogenesis.
Kirsten大鼠肉瘤病毒癌基因同源物(KRAS)突变和慢性胰腺炎是人类胰腺癌发生过程中最常见的致病事件。在长期慢性炎症过程中,花生四烯酸的异常代谢产物在促进癌症发生中起关键作用,其中可溶性环氧化物水解酶(sEH)作为一种促炎酶,通常会使抗炎性环氧二十碳三烯酸(EETs)失活。在此,我们确定了我们新合成的新型化合物反式-4-{4-[3-(4-氯-3-三氟甲基苯基)-脲基]-环己氧基}-吡啶-2-羧酸甲酰胺(t-CUPM),一种sEH和RAF1原癌基因丝氨酸/苏氨酸激酶(c-RAF)的双重抑制剂,对抑制LSL-Kras(G12D)/Pdx1-Cre小鼠胰腺炎和胰腺上皮内瘤变(mPanIN)发展的作用。结果表明,t-CUPM显著降低了慢性胰腺炎的严重程度,通过腺泡丢失程度、炎性细胞浸润和间质纤维化来衡量。低级别mPanIN I向高级别mPanIN II/III的进展受到显著抑制。通过蛋白质免疫印迹法在胰腺组织中证实了对突变型Kras介导的丝裂原活化蛋白激酶激酶/细胞外信号调节激酶磷酸化的抑制作用。定量实时聚合酶链反应分析显示,t-CUPM处理显著降低了包括肿瘤坏死因子-α、单核细胞趋化蛋白-1以及血管黏附分子-1等炎性细胞因子的水平,以及音猬因子和Gli转录因子(Hedgehog信号通路)的水平。类花生酸谱分析显示EETs / 二羟基二十碳三烯酸比值显著增加,这进一步证实了t-CUPM对sEH的抑制作用。这些结果表明,t-CUPM同时抑制sEH和c-RAF在预防慢性胰腺炎和癌症发生中具有重要作用。